Vasoactive intestinal peptide (VIP) enhances the cell motility of androgen receptor-transfected DU-145 prostate cancer cells (DU-145/AR).

Source:http://linkedlifedata.com/resource/pubmed/id/11790458

Cancer Lett. 2002 Feb 8 176 1 93-9

Download in:

View as

General Info

PMID
11790458